Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Latest
Popular
Free webinar: Telepathology: is there added value in LMICs?
Free webinar: Telepathology: is there added value in LMICs?

Outcome of third salvage autologous stem cell transplantation in multiple myeloma

Dr Laurent Garderet - Hôpital Saint Antoine, Paris, France
Outcome of third salvage autologous stem cell transplantation in multiple myeloma ( Dr Laurent Garderet - Hôpital Saint Antoine, Paris, France )
7 Mar 2017

Treatment of multiple myeloma patients in the relapsed setting: Expert discussion from IMW 2017

Prof Maria-Victoria Mateos, Prof Paul Richardson
Treatment of multiple myeloma patients in the relapsed setting: Expert discussion from IMW 2017 ( Prof Maria-Victoria Mateos, Prof Paul Richardson )
5 Mar 2017

Evaluating efficacy of denosumab compared with zoledronic acid in symptomatic myeloma

Dr Noopar Raje - Massachusetts General Hospital, Boston, USA
Evaluating efficacy of denosumab compared with zoledronic acid in symptomatic myeloma ( Dr Noopar Raje - Massachusetts General Hospital, Boston, USA )
4 Mar 2017

Multiple myeloma highlights from IMW 2017

Prof Phillipe Moreau, Prof Philip McCarthy, Prof Jens Hillengass, Prof Meletios Dimopoulos
Multiple myeloma highlights from IMW 2017 ( Prof Phillipe Moreau, Prof Philip McCarthy, Prof Jens Hillengass, Prof Meletios Dimopoulos )
4 Mar 2017

Long term effects of myeloma treatment

Monica Morris - Myeloma UK, Edinburgh, UK
Long term effects of myeloma treatment ( Monica Morris - Myeloma UK, Edinburgh, UK )
3 Mar 2017

Update on CASTOR trial: Daratumumab, bortezomib, and dexamethasone for relapsed or refractory myeloma

Dr Suzanne Lentzsch - Columbia University, New York, USA
Update on CASTOR trial: Daratumumab, bortezomib, and dexamethasone for relapsed or refractory myeloma ( Dr Suzanne Lentzsch - Columbia University, New York, USA )
3 Mar 2017

Caring for multiple myeloma carers

Monica Morris - Myeloma UK, Edinburgh, UK
Caring for multiple myeloma carers ( Monica Morris - Myeloma UK, Edinburgh, UK )
3 Mar 2017

Impact of recurrent myeloma alterations on drug response

Dr Muntasir Mamun Majumder - University of Helsinki, Helsinki, Finland
Impact of recurrent myeloma alterations on drug response ( Dr Muntasir Mamun Majumder - University of Helsinki, Helsinki, Finland )
3 Mar 2017

What is the biology behind immunotherapy for MM?

Dr Alexander Lesokhin - Memorial Sloan Kettering Cancer Center, New York, USA
What is the biology behind immunotherapy for MM? ( Dr Alexander Lesokhin - Memorial Sloan Kettering Cancer Center, New York, USA )
3 Mar 2017

Evolving role of MRD negativity in multiple myeloma

Prof Jesús San Miguel - University Hospital, Salamanca, Spain
Evolving role of MRD negativity in multiple myeloma ( Prof Jesús San Miguel - University Hospital, Salamanca, Spain )
3 Mar 2017

Role of immunotherapy and precision medicines in multiple myeloma and key new guidelines

Prof Sagar Lonial - Emory University, Atlanta, USA
Role of immunotherapy and precision medicines in multiple myeloma and key new guidelines ( Prof Sagar Lonial - Emory University, Atlanta, USA )
3 Mar 2017

Carfilzomib, cyclophosphamide, and dexamethasone in newly diagnosed multiple myeloma

Dr Ralph Boccia - Center for Cancer and Blood Disorders, Bethesda, USA
Carfilzomib, cyclophosphamide, and dexamethasone in newly diagnosed multiple myeloma ( Dr Ralph Boccia - Center for Cancer and Blood Disorders, Bethesda, USA )
3 Mar 2017

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation